Cat.#: ACPP-1324
Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1322 | TRPM8 Blocking Peptide (AC1322) | 250 µg | inquiry |
ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
ACPP-1110 | Recombinant Human ROR1 Protein (6×His Tag) (AC1110) | 50 µg | inquiry |
ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
ACPP-1441 | Human HOMER1 Protein (AC1441) | 5 µg | inquiry |
ACPP-1319 | Axin 2 Blocking Peptide (AC1319) | 250 µg | inquiry |
ACPP-1588 | Human GABARAP Protein (AC1588) | 10 µg | inquiry |
ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.